The glucagon receptor antagonist desHis1Pro4Glu9-glucagon(Lys12PAL) alters alpha-cell turnover and lineage in mice, but does not cause alpha-cell hyperplasia-Reference-Cited by-同舟云学术

The glucagon receptor antagonist desHis1Pro4Glu9-glucagon(Lys12PAL) alters alpha-cell turnover and lineage in mice, but does not cause alpha-cell hyperplasia

Published:2023-06 Issue: Volume:570 Page:111932
ISSN:0303-7207
Container-title:Molecular and Cellular Endocrinology
language:en
Short-container-title:Molecular and Cellular Endocrinology

Author:

Lafferty Ryan^ORCID,Tanday Neil^ORCID,Dubey Vaibhav^ORCID,Coulter-Parkhill Aimee^ORCID,Vishal Karthick,Moffett Charlotte,O'Harte Finbarr,Flatt Peter R.,Irwin Nigel^ORCID

Publisher

Elsevier BV

Subject

Endocrinology,Molecular Biology,Biochemistry

Reference50 articles.

1. Development of potent glucagon antagonists: structure-activity relationship study of glycine at position 4;Ahn;J. Pept. Res.,2001

2. Structural basis for delta cell paracrine regulation in pancreatic islets;Arrojo E Drigo;Nat. Commun.,2019

3. Essential role of syntaxin-binding protein-1 in the regulation of glucagon-like peptide-1 secretion;Campbell;Endocrinology,2020

4. Human islets contain a subpopulation of glucagon-like peptide-1 secreting α cells that is increased in type 2 diabetes;Campbell;Mol. Metabol.,2020

5. Pro-α-cell-derived β-cells contribute to β-cell neogenesis induced by antagonistic glucagon receptor antibody in type 2 diabetic mice;Cui;iScience,2022

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glucagon-based therapy for people with diabetes and obesity: What is the sweet spot?;Peptides;2024-06

2. Mechano-sensor Piezo1 inhibits glucagon production in pancreatic α-cells;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-06